Pluri Inc. Postemployment Benefits, Period Expense
Pluri Inc. (PLUR) reported Postemployment Benefits, Period Expense of $822.00 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PostemploymentBenefitsPeriodExpense · last filed 2018-09-12
- Pluri Inc. postemployment benefits, period expense for fiscal 2018 was $822.00K, a 56.87% increase from fiscal 2017.
- Pluri Inc. postemployment benefits, period expense for fiscal 2017 was $524.00K, a 5.76% decline from fiscal 2016.
- Pluri Inc. postemployment benefits, period expense for fiscal 2016 was $556.00K, a 26.08% increase from fiscal 2015.
- Pluri Inc. postemployment benefits, period expense for fiscal 2015 was $441.00K, a 17.42% decline from fiscal 2014.
| Period end | Postemployment Benefits, Period Expense 12 month |
|---|---|
| 2018-06-30 | $822.00K 10-K · filed 2018-09-12 |
| 2017-06-30 | $524.00K 10-K · filed 2018-09-12 |
| 2016-06-30 | $556.00K 10-K · filed 2018-09-12 |
| 2015-06-30 | $441.00K 10-K · filed 2017-09-07 |
| 2014-06-30 | $534.00K 10-K · filed 2016-09-07 |
| 2013-06-30 | $329.00K 10-K · filed 2015-09-09 |
| 2012-06-30 | $275.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |